Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126923832 | 12692383 | 2 | F | 201607 | 20160831 | 20160828 | 20160907 | PER | US-SHIRE-US201610815 | SHIRE | 36.16 | YR | F | Y | 102.40000 | KG | 20160907 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126923832 | 12692383 | 1 | PS | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | Oral | 40 MG, 2X/DAY:BID | 3139733 | 21977 | 40 | MG | CAPSULE | BID | |||||
| 126923832 | 12692383 | 2 | SS | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | Oral | UNK UNK, OTHER (SPLITTING DOSES) | 21977 | CAPSULE | |||||||||
| 126923832 | 12692383 | 3 | C | LAMICTAL | LAMOTRIGINE | 1 | Oral | 75 MG, 1X/DAY:QD | 0 | 75 | MG | TABLET | QD | ||||||
| 126923832 | 12692383 | 4 | C | XANAX | ALPRAZOLAM | 1 | Oral | 1 OR 2 MG, 1X/DAY:QD | 0 | TABLET | QD | ||||||||
| 126923832 | 12692383 | 5 | C | ATIVAN | LORAZEPAM | 1 | Oral | 1 MG, AS REQ'D | 0 | 1 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126923832 | 12692383 | 1 | Attention deficit/hyperactivity disorder |
| 126923832 | 12692383 | 3 | Depression |
| 126923832 | 12692383 | 4 | Sleep disorder |
| 126923832 | 12692383 | 5 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126923832 | 12692383 | Disturbance in attention | |
| 126923832 | 12692383 | Drug effect decreased | |
| 126923832 | 12692383 | Inappropriate schedule of drug administration | |
| 126923832 | 12692383 | Incorrect dose administered | |
| 126923832 | 12692383 | Prescribed overdose | |
| 126923832 | 12692383 | Product quality issue | |
| 126923832 | 12692383 | Therapeutic response decreased | |
| 126923832 | 12692383 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126923832 | 12692383 | 3 | 2008 | 0 | ||
| 126923832 | 12692383 | 4 | 2006 | 0 | ||
| 126923832 | 12692383 | 5 | 2008 | 0 |